Literature DB >> 18379864

Cellular replacement therapy for arrhythmia treatment: early clinical experience.

Demosthenes Katritsis1.   

Abstract

Clinical and experimental studies have demonstrated the proarrhythmic potential of skeletal myoblast transplantation for repair of infarcted myocardium. The evidence on proarrhythmia following bone marrow-derived stem cells, and particular msenchymal stem cells, transplantation is inconclusive. There are experimental and preliminary clinical data supporting the possibility that mesenchymal stem cell transplantation might exert an anti-arrhythmic action by intervening with myocardial scar remodeling. However, clinical experience is limited.

Entities:  

Mesh：

Year:  2008        PMID： 18379864     DOI： 10.1007/s10840-008-9244-z

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


  59 in total

1.  Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study.

Authors:  Sandra Erbs; Axel Linke; Volker Adams; Karsten Lenk; Holger Thiele; Klaus-Werner Diederich; Frank Emmrich; Regine Kluge; Kai Kendziorra; Osama Sabri; Gerhard Schuler; Rainer Hambrecht
Journal:  Circ Res       Date:  2005-09-08       Impact factor: 17.367

Review 2.  Can stem cells mend a broken heart?

Authors:  Siamak Davani; Frédéric Deschaseaux; David Chalmers; Pierre Tiberghien; Jean-Pierre Kantelip
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

3.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

4.  Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Authors:  Nabil Dib; Robert E Michler; Francis D Pagani; Susan Wright; Dean J Kereiakes; Rose Lengerich; Philip Binkley; Diane Buchele; Inder Anand; Cory Swingen; Marcelo F Di Carli; James D Thomas; Wael A Jaber; Shaun R Opie; Ann Campbell; Patrick McCarthy; Michael Yeager; Vasken Dilsizian; Bartley P Griffith; Ronald Korn; Steven K Kreuger; Marwan Ghazoul; W Robb MacLellan; Gregg Fonarow; Howard J Eisen; Jonathan Dinsmore; Edward Diethrich
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

5.  Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.

Authors:  Albert A Hagège; Jean-Pierre Marolleau; Jean-Thomas Vilquin; Armelle Alhéritière; Séverine Peyrard; Denis Duboc; Eric Abergel; Emmanuel Messas; Elie Mousseaux; Ketty Schwartz; Michel Desnos; Philippe Menasché
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.

Authors:  Hyun-Jae Kang; Hae-Young Lee; Sang-Hoon Na; Sung-A Chang; Kyung-Woo Park; Hyung-Kwan Kim; Song-Yi Kim; Ho-Joon Chang; Whal Lee; Won Jun Kang; Bon-Kwon Koo; Yong-Jin Kim; Dong Soo Lee; Dae-Won Sohn; Kyou-Sup Han; Byung-Hee Oh; Young-Bae Park; Hyo-Soo Kim
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

7.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

8.  Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures.

Authors:  Saskia L M A Beeres; Douwe E Atsma; Arnoud van der Laarse; Daniël A Pijnappels; John van Tuyn; Willem E Fibbe; Antoine A F de Vries; Dirk L Ypey; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2005-10-21       Impact factor: 24.094

9.  Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Nikos Werner; Jürgen Haase; Jörg Neuzner; Alfried Germing; Bernd Mark; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Eur Heart J       Date:  2006-11-10       Impact factor: 29.983

10.  Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

Authors:  Douglas W Losordo; Richard A Schatz; Christopher J White; James E Udelson; Vimal Veereshwarayya; Michelle Durgin; Kian Keong Poh; Robert Weinstein; Marianne Kearney; Muqtada Chaudhry; Aaron Burg; Liz Eaton; Lindsay Heyd; Tina Thorne; Leon Shturman; Peter Hoffmeister; Ken Story; Victor Zak; Douglas Dowling; Jay H Traverse; Rachel E Olson; Janice Flanagan; Donata Sodano; Toshinori Murayama; Atsuhiko Kawamoto; Kengo Fukushima Kusano; Jill Wollins; Frederick Welt; Pinak Shah; Peter Soukas; Takayuki Asahara; Timothy D Henry
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690
View more
  1 in total

Review 1.  Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis.

Authors:  Neil H Riordan; Thomas E Ichim; Wei-Ping Min; Hao Wang; Fabio Solano; Fabian Lara; Miguel Alfaro; Jorge Paz Rodriguez; Robert J Harman; Amit N Patel; Michael P Murphy; Roland R Lee; Boris Minev
Journal:  J Transl Med       Date:  2009-04-24       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.